{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T05:12:00Z","timestamp":1780895520246,"version":"3.54.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.transci.2009.05.014","type":"journal-article","created":{"date-parts":[[2009,6,22]],"date-time":"2009-06-22T09:38:02Z","timestamp":1245663482000},"page":"61-65","source":"Crossref","is-referenced-by-count":15,"title":["Comparison of different Lp (a) elimination techniques: A retrospective evaluation"],"prefix":"10.1016","volume":"41","author":[{"given":"Helmut","family":"Borberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2009.05.014_bib1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1749-6632.1994.tb17328.x","article-title":"Genetic architecture of the atherogenic lipoprotein(a)","volume":"748","author":"Utermann","year":"1995","journal-title":"Ann NY Acad Sci"},{"issue":"5","key":"10.1016\/j.transci.2009.05.014_bib2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1399-0004.1997.tb04352.x","article-title":"Metabolism of Lp(a): assembly and excretion","volume":"52","author":"Kostner","year":"1997","journal-title":"Clin Genet"},{"issue":"8","key":"10.1016\/j.transci.2009.05.014_bib3","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/hmg\/10.8.815","article-title":"Single nucleotide polymorphisms in exons of the apo(a) kringles IV types 6\u201310 domain affect Lp(a) plasma concentrations and have different patterns in Africans and Caucasians","volume":"10","author":"Ogorelkova","year":"2001","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1016\/j.transci.2009.05.014_bib4","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3109\/10408369609080056","article-title":"Lipoprotein(a) in health and disease","volume":"33","author":"Kronenberg","year":"1996","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"11","key":"10.1016\/j.transci.2009.05.014_bib5","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1161\/01.CIR.100.11.1154","article-title":"Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study","volume":"100","author":"Kronenberg","year":"1999","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.transci.2009.05.014_bib6","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/01.ATV.20.2.522","article-title":"Lipoprotein(a) in homozygous familial hypercholesterolemia","volume":"20","author":"Kraft","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.transci.2009.05.014_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1358\/dnp.2002.15.2.668328","article-title":"The physiological role of lipoprotein (a)","volume":"15","author":"Kostner","year":"2002","journal-title":"Drug News Perspect"},{"issue":"4","key":"10.1016\/j.transci.2009.05.014_bib8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00041433-200208000-00006","article-title":"Lipoprotein(a): still an enigma?","volume":"13","author":"Kostner","year":"2002","journal-title":"Curr Opin Lipidol"},{"issue":"2","key":"10.1016\/j.transci.2009.05.014_bib9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1055\/s-0037-1615178","article-title":"Plasma Lp(a) levels are increased in patients with chronic thromboembolic pulmonary hypertension","volume":"80","author":"Ignatescu","year":"1998","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.transci.2009.05.014_bib10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1023\/A:1008983110941","article-title":"Plasmin activation system in restenosis: role in pathogenesis and clinical prediction?","volume":"7","author":"Christ","year":"1999","journal-title":"J Thromb Thrombolys"},{"issue":"10","key":"10.1016\/j.transci.2009.05.014_bib11","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1182\/blood.V98.10.2980","article-title":"Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis","volume":"98","author":"Caplice","year":"2001","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.transci.2009.05.014_bib12","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1182\/blood.V97.4.981","article-title":"Lipoprotein (a) up-regulates the expression of the plasminogen activator inhibitor 2 in human blood monocytes","volume":"97","author":"Buechler","year":"2001","journal-title":"Blood"},{"issue":"29","key":"10.1016\/j.transci.2009.05.014_bib13","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.2174\/1381612033453820","article-title":"The effects of lipid-regulating therapy on haemostatic parameters","volume":"9","author":"Milionis","year":"2003","journal-title":"Curr Pharm Des"},{"issue":"8","key":"10.1016\/j.transci.2009.05.014_bib14","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.amjmed.2003.06.005","article-title":"Increased plasma levels of lipoprotein(a) and the risk of idiopathic and recurrent venous thromboembolism","volume":"115","author":"Marcucci","year":"2003","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.transci.2009.05.014_bib15","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1161\/01.ATV.8.4.398","article-title":"Lipoprotein Lp(a). A risk factor for myocardial infarction","volume":"8","author":"Hoefler","year":"1988","journal-title":"Arteriosclerosis"},{"issue":"1","key":"10.1016\/j.transci.2009.05.014_bib16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/clinchem\/36.1.20","article-title":"Lipoprotein (a) is an independent risk factor for myocardial infarction at a young age","volume":"36","author":"Sandkamp","year":"1990","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.transci.2009.05.014_bib17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/jcp.46.3.267","article-title":"Lipoprotein (a) as an independent risk factor for myocardial infarction in patients with common hypercholesterolaemia","volume":"46","author":"Watts","year":"1993","journal-title":"J Clin Pathol"},{"issue":"4","key":"10.1016\/j.transci.2009.05.014_bib18","first-page":"1132","article-title":"Is lipoprotein (a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study","volume":"32","author":"Cantin","year":"1998","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.transci.2009.05.014_bib19","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1399-0004.1997.tb04344.x","article-title":"Lp(a) lipoprotein is a major risk factor for cardiovascular disease: pathogenic mechanisms and clinical significance","volume":"562","author":"Dahlen","year":"1997","journal-title":"Clin Genet"},{"issue":"7","key":"10.1016\/j.transci.2009.05.014_bib20","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/jama.1996.03540070040028","article-title":"Elevated plasma lipoprotein (a) and coronary heart disease in men aged 55 years and younger. A prospective study","volume":"276","author":"Bostom","year":"1996","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.transci.2009.05.014_bib21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1253\/jcj.64.51","article-title":"Lipoprotein (a) is a potential coronary risk factor","volume":"64","author":"Fujino","year":"2000","journal-title":"Jpn Circ J"},{"issue":"2","key":"10.1016\/j.transci.2009.05.014_bib22","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0021-9150(98)00174-9","article-title":"Lipoprotein (a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease: results from the NHLBI Family Heart Study","volume":"141","author":"Hopkins","year":"1998","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.transci.2009.05.014_bib23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/sj.ejhg.5200152","article-title":"Concentrations of the atherogenic Lp(a) are elevated in FH","volume":"6","author":"Lingenhel","year":"1998","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"10.1016\/j.transci.2009.05.014_bib24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF02912466","article-title":"Apolipoproteins and lipoprotein particles in Moroccan patients with previous myocardial infarction","volume":"27","author":"Adlouni","year":"1997","journal-title":"Int J Clin Lab Res"},{"issue":"2","key":"10.1016\/j.transci.2009.05.014_bib25","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0735-1097(00)01126-8","article-title":"Lipoprotein (a) further increases the risk of coronary events in men with high global cardiovascular risk","volume":"37","author":"Von Eckardstein","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.transci.2009.05.014_bib26","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0021-9150(00)00719-X","article-title":"Lipoprotein (a) and development of intermittent claudication and major cardiovascular events in men and women: The Edinburgh Artery Study","volume":"157","author":"Price","year":"2001","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.transci.2009.05.014_bib27","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0002-9149(01)02336-0","article-title":"Association of fibrinogen and lipoprotein (a) as a coronary heart disease risk factor in men (The Quebec Cardiovascular Study)","volume":"89","author":"Cantin","year":"2002","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.transci.2009.05.014_bib28","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1681\/ASN.V61110","article-title":"Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis","volume":"6","author":"Kronenberg","year":"1995","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.transci.2009.05.014_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-6386(96)90026-8","article-title":"Lipoprotein (a) in renal disease","volume":"27","author":"Kronenberg","year":"1996","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1016\/j.transci.2009.05.014_bib30","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0022-2275(20)37150-9","article-title":"Renovascular arteriovenous differences in Lp[a] plasma concentrations suggest removal of Lp[a] from the renal circulation","volume":"38","author":"Kronenberg","year":"1997","journal-title":"J Lipid Res"},{"issue":"5","key":"10.1016\/j.transci.2009.05.014_bib31","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1399-0004.1997.tb04357.x","article-title":"LDL-unbound apolipoprotein(a) and carotid atherosclerosis in hemodialysis patients","volume":"52","author":"Kronenberg","year":"1997","journal-title":"Clin Genet"},{"issue":"1","key":"10.1016\/j.transci.2009.05.014_bib32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1365-2362.1997.00108.x","article-title":"LDL-apheresis significantly reduces urinary apo(a) excretion","volume":"27","author":"Kostner","year":"1997","journal-title":"Eur J Clin Invest"},{"issue":"6","key":"10.1016\/j.transci.2009.05.014_bib33","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1046\/j.1365-2362.1998.00319.x","article-title":"Decreased urinary apolipoprotein (a) excretion in patients with impaired renal function","volume":"28","author":"Kostner","year":"1998","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"10.1016\/j.transci.2009.05.014_bib34","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0021-9150(99)00014-3","article-title":"Lipoprotein(a) plasma concentrations after renal transplantation: a prospective evaluation after 4 years of follow-up","volume":"144","author":"Kerschdorfer","year":"1999","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.transci.2009.05.014_bib35","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1093\/ndt\/gfg181","article-title":"Relationship of non-LDL-bound apo(a), urinary apo(a) fragments and plasma Lp(a) in patients with impaired renal function","volume":"18","author":"Cauza","year":"2003","journal-title":"Nephrol Dial Transplant"},{"issue":"21","key":"10.1016\/j.transci.2009.05.014_bib36","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/jama.1997.03540450045033","article-title":"Association of serum lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension","volume":"277","author":"Sechi","year":"1997","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.transci.2009.05.014_bib37","first-page":"1013","article-title":"Lipoprotein (a) concentration and apolipoprotein (a) phenotype in subjects with type 2 diabetes mellitus","volume":"111","author":"Shi","year":"1998","journal-title":"Chin Med J"},{"issue":"8","key":"10.1016\/j.transci.2009.05.014_bib38","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s001250051263","article-title":"Is apolipoprotein(a) a susceptibility gene for type I diabetes mellitus and related to long-term survival?","volume":"42","author":"Kronenberg","year":"1999","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.transci.2009.05.014_bib39","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0009-9120(03)00065-1","article-title":"Apoprotein(a) phenotypes and plasma lipoprotein(a) concentration in patients with diabetes mellitus","volume":"36","author":"Labudovic","year":"2003","journal-title":"Clin Biochem"},{"issue":"2","key":"10.1016\/j.transci.2009.05.014_bib40","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1600-0404.1996.tb07042.x","article-title":"Case-control study of serum lipoprotein (a) and apolipoproteins A-I and B in stroke in the young","volume":"94","author":"Christopher","year":"1996","journal-title":"Acta Neurol Scan"},{"issue":"5","key":"10.1016\/j.transci.2009.05.014_bib41","first-page":"397","article-title":"Lipoprotein (a) and cerebral infarction in young adults","volume":"24","author":"Cao","year":"2003","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"1","key":"10.1016\/j.transci.2009.05.014_bib42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1067\/mva.2002.124371","article-title":"Lipoprotein (a) in patients with aortic aneurysmal disease","volume":"36","author":"Schillinger","year":"2002","journal-title":"J Vasc Surg"},{"issue":"2","key":"10.1016\/j.transci.2009.05.014_bib43","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1525-1594.1991.tb00771.x","article-title":"Immunosorbent for selective removal of lipoprotein (a) from human plasma: in vitro study","volume":"15","author":"Pokrovsky","year":"1991","journal-title":"Artif Organs"},{"key":"10.1016\/j.transci.2009.05.014_bib44","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0009-3084(94)90153-8","article-title":"Extracorporeal immunoadsorption for the specific removal of lipoprotein (a) (Lp(a) apheresis): preliminary clinical data","volume":"67\u201368","author":"Pokrovsky","year":"1994","journal-title":"Chem Phys Lipids"},{"issue":"4","key":"10.1016\/j.transci.2009.05.014_bib45","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0022-5223(03)00365-9","article-title":"Association of lipoprotein(a) excess with early vein graft occlusions in middle-aged men undergoing coronary artery bypass surgery","volume":"126","author":"Pokrovsky","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"10.1016\/j.transci.2009.05.014_bib46","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0021-9150(02)00026-6","article-title":"PRIME Study Group lipoprotein (a) as an predictor of coronary heart disease: The Prime Study","volume":"163","author":"Luc","year":"2002","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.transci.2009.05.014_bib47","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0002-9149(02)02192-6","article-title":"Relation of lipoprotein (a) as coronary risk factor to type 2 diabetes mellitus and low-density lipoprotein cholesterol in patients>or=65 years of age (The Italian Longitudinal Study on Aging, ILSA)","volume":"89","author":"Solfrizzi","year":"2002","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.transci.2009.05.014_bib48","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1399-0004.1997.tb04359.x","article-title":"Standardization of Lp(a) measurements","volume":"52","author":"Kostner","year":"1997","journal-title":"Clin Genet"},{"issue":"12","key":"10.1016\/j.transci.2009.05.014_bib49","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/S0022-2275(20)32100-3","article-title":"Preparation of a stable fresh frozen primary lipoprotein[a] (Lp[a]) standard","volume":"40","author":"Kostner","year":"1999","journal-title":"J Lipid Res"},{"issue":"8 Pt 1","key":"10.1016\/j.transci.2009.05.014_bib50","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1093\/clinchem\/44.8.1629","article-title":"International Federation of Clinical Chemistry standardization project for the measurement of lipoprotein (a). Phase I: evaluation of the analytical performance of lipoprotein (a) assay systems and commercial calibrators","volume":"44","author":"Tate","year":"1998","journal-title":"Clin Chem"},{"issue":"10","key":"10.1016\/j.transci.2009.05.014_bib51","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1515\/CCLM.1999.140","article-title":"International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) standardization project for the measurement of lipoprotein(a). Phase 2: selection and properties of a proposed secondary reference material for lipoprotein (a)","volume":"37","author":"Tate","year":"1999","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"10.1016\/j.transci.2009.05.014_bib52","first-page":"374","article-title":"Lipoprotein (a) determination and risk of cardiovascular disease in South African patients with familial hypercholesterolaemia","volume":"90","author":"Scholtz","year":"2000","journal-title":"S Afr Med J"},{"issue":"1","key":"10.1016\/j.transci.2009.05.014_bib53","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0002-9343(00)00652-5","article-title":"Lipoprotein (a) as a predictor of myocardial infarction in middle-aged men","volume":"110","author":"Seed","year":"2001","journal-title":"Am J Med"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050209000858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050209000858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T17:44:47Z","timestamp":1633628687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050209000858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S1473050209000858"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2009.05.014","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}